Food addiction in eating disorders and obesity : analysis of clusters and implications for treatment by Jiménez-Murcia, Susana et al.
nutrients
Article
Food Addiction in Eating Disorders and Obesity:
Analysis of Clusters and Implications for Treatment
Susana Jiménez-Murcia 1,2,3,*, Zaida Agüera 1,2,4 , Georgios Paslakis 5,6 , Lucero Munguia 3,
Roser Granero 2,7 , Jéssica Sánchez-González 1, Isabel Sánchez 1,2, Nadine Riesco 1,2,
Ashley N Gearhardt 8, Carlos Dieguez 2,9, Gilda Fazia 10,11, Cristina Segura-García 11,12 ,
Isabel Baenas 1, José M Menchón 1,3,13 and Fernando Fernández-Aranda 1,2,3,*
1 Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, L’Hospitalet de Llobregat,
08907 Barcelona, Spain; zaguera@bellvitgehospital.cat (Z.A.); jsanchezg@bellvitgehospital.cat (J.S.-G.);
isasanchez@bellvitgehospital.cat (I.S.); nriesco@bellvitgehospital.cat (N.R.);
ibaenas@bellvitgehospital.cat (I.B.); jmenchon@bellvitgehospital.cat (J.M.M.)
2 CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, L’Hospitalet de
Llobregat, 08907 Barcelona, Spain; roser.granero@uab.cat (R.G.); carlos.dieguez@usc.es (C.D.)
3 Clinical Sciences Department, School of Medicine, University of Barcelona, 08907 L’Hospitalet de Llobregat,
Spain; laarcreed_lm@hotmail.com
4 Department of Public Health, Mental Health and Maternal-Child Nursing, School of Nursing, University of
Barcelona, 08907 L’Hospitalet de Llobregat, Spain
5 Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada; paslakis@outlook.de
6 Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada
7 Department of Psychobiology and Methodology, Autonomous University of Barcelona,
08193 Barcelona, Spain
8 Department of Psychology, University of Michigan, Ann Arbor, MI 48109, USA; agearhar@umich.edu
9 Department Physiology, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Health
Research Institute of Santiago USC-IDIS, University Santiago de Compostela,
15705 Santiago de Compostela, Spain
10 Department of Health Sciences, University “Magna Graecia” of Catanzaro, Viale Europa, 88100 Catanzaro,
Italy; gildafazia@gmail.com
11 Center for Clinical Research and Treatment of Eating Disorders, Azienda Ospedaliera Universitaria Mater
Domini, 88100 Catanzaro, Italy; segura@unicz.it
12 Department of Medical and Surgical Sciences, University “Magna Graecia” of Catanzaro,
88100 Catanzaro, Italy
13 CIBER de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, L’Hospitalet de Llobregat,
08907 Barcelona, Spain
* Correspondence: sjimenez@bellvitgehospital.cat (S.J.-M.); ffernandez@bellvitgehospital.cat (F.F.-A.);
Tel.: +34 93 260 79 88 (S.J.-M.); +34-932-60-72-27 (F.F.-A.)
Received: 31 July 2019; Accepted: 14 October 2019; Published: 3 November 2019


Abstract: Food addiction (FA) has been associated with greater psychopathology in individuals with
eating disorders (ED) and obesity (OBE). The current study aims to provide a better phenotypic
characterization of the FA construct by conducting a clustering analysis of FA in both conditions
(ED and OBE). The total sample was comprised of 234 participants that scored positive on the Yale
Food Addiction Scale 2.0. (YFAS-2) (119 bulimia nervosa (BN), 50 binge eating disorder (BED),
49 other specified feeding or eating disorder (OSFED) and 16 OBE). All participants completed a
comprehensive battery of questionnaires. Three clusters of FA participants were identified. Cluster 1
(dysfunctional) was characterized by the highest prevalence of OSFED and BN, the highest ED severity
and psychopathology, and more dysfunctional personality traits. Cluster 2 (moderate) showed a high
prevalence of BN and BED and moderate levels of ED psychopathology. Finally, cluster 3 (adaptive)
was characterized by a high prevalence of OBE and BED, low levels of ED psychopathology, and more
functional personality traits. In conclusion, this study identified three distinct clusters of ED-OBE
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patients with FA and provides some insight into a better phenotypic characterization of the FA
construct when considering psychopathology, personality and ED pathology. Future studies should
address whether these three food addiction categories are indicative of therapy outcome.
Keywords: food addiction; eating disorders; bulimia nervosa; binge eating disorders; obesity; other
specified feeding or eating disorders; cluster analysis
1. Introduction
Food addiction (FA) is a concept that has been of increasing scientific interest and debate.
An immense body of literature within the field of eating disorder (ED) research has emerged,
with whole special issues of scientific journals being dedicated to its characterization [1,2]. In addition
to obvious phenomenological similarities between addiction and ED (e.g., loss of control, continued use
despite negative consequences, cravings), a great number of neurobiological findings have emerged to
additionally support the new concept, not only in preclinical studies, but also in humans [3–6].
Still, not all controversies have yet been resolved. Starting off as a concept to explain a potential
subtype of obesity (OBE) [7–10], FA has also been associated with ED, such as bulimia nervosa
(BN) [11–13], binge eating disorder (BED) [14–16], and even anorexia nervosa (AN) [17]. In a systematic
review of studies on FA in non-clinical and clinical cohorts, it was especially BED that was associated
with the most severe FA symptoms [15]. FA also seems to be prevalent in individuals with OBE
waiting for bariatric surgery [18,19] and predicts less effective weight reduction throughout dietary
intervention before surgery [20]. Interestingly, surgery-induced weight loss may lead to remission of
FA [21,22].
The Yale Food Addiction Scale (YFAS) is the main instrument for the assessment of FA and
has been developed to assess FA based on the known criteria used for the assessment of substance
dependence, but applied for high palatable foods [23,24]. Higher scores on the YFAS have been
associated with higher body mass index (BMI), binge eating episodes, impulsivity, and cravings for
highly palatable food [25], as well as with neural responses similar to those found in substance use
disorders [26–29].
There is scarce evidence with regard to the identification of key determinants of FA based on
personality traits or ED-related symptoms and most of what is known is derived from non-clinical
cohorts. In a non-clinical sample, negative urgency (irrational acting in aversive affective states) and low
levels of task persistence (lack of perseverance) were shown to be significantly and directly associated
with FA and FA mediated their association to BMI [30]. In another study in undergraduates, negative
urgency, impulsivity when under distress, and emotion dysregulation positively predicted symptom
count on the YFAS [31]. Similar findings were shown in a clinical ED cohort, although negative
urgency appeared to be the only independent predictor for FA, while self-directedness and emotion
dysregulation predicted negative urgency and were highly related to ED-related symptomatology,
but not to food addiction itself [32,33]. In individuals with OBE awaiting bariatric surgery, FA was
associated with personality traits such as neuroticism, impulsivity, and alexithymia [34], but also more
emotion dysregulation, more harm avoidance, and less self-directedness [35].
FA has also been associated with a positive screen for more severe variants of ED-related
psychopathology [7] as well as with a positive screen for major mental health symptoms, major
depressive episode, anxiety, early life adversities, such as psychological and sexual abuse, and
an overall reduced quality of life [36–38]. Finally, female gender was a predictor of severe food
addiction [36] and high reward sensitivity was significantly associated with more severe FA symptoms
in females [39].
Due to these meaningful interrelationships in the literature between FA and personality traits,
as well as psychopathology, it is important to consider the association of FA with these factors in an
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integrated way (rather than looking at each construct in isolation). Evaluating how personality and
psychopathology cluster within the FA construct could lead to a better understanding of potential
distinct phenotypes within FA that could have different clinical profiles.
Based on this premise, the aim of the present paper was to explore empirically the severity of
clusters of FA-positive (FA+) participants based on psychopathological symptomatology (namely
ED-related psychopathology and general psychopathology) and personality traits, and to investigate
how the clinical features and diagnosis of ED and OBE were distributed among them. This is the first
study that attempts this type of analysis in order to identify subgroups among participants with positive
FA in order to provide a better phenotypic characterization of the FA construct. We hypothesized that,
despite overlaps, patients with ED would predominantly fit into a cluster characterized by a more
severe ED-related psychopathology that would be different than the cluster predominantly found
among individuals with OBE. We then evaluated whether there were differences by ED subtypes, with
a subgroup of patients (basically BED, but also BN) who are more similar to participants with OBE. We
also hypothesized that, among others, ED-related severity, general psychopathology, and personality
traits would be important determinants of the FA phenotypes. The rationale for performing this kind
of analysis was to gain insight into the possibility of different FA clusters that would ideally translate
into future symptom-targeted treatments for FA phenotypes in individuals with OBE and for those
suffering from ED.
2. Materials and Methods
2.1. Participants
From an initial sample of 395, the final participants of the current study were 234 females who
scored positive for the FA (based on YFAS 2.) and who also had a diagnosis of ED or OBE (119 with
BN, 50 with BED, 49 with other specified feeding or eating disorder (OSFED), and 16 with OBE).
All participants in the OBE group (n = 16) as well as n = 42 participants in the BED group (84.0%),
n = 27 in the BN group (22.7%), and n = 2 in the OSFED group (4.1%) had a BMI higher than 30. All
participants included in the study were consecutively referred for assessment and treatment at the
Unit of Eating Disorders of the Department of Psychiatry of the University Hospital of Bellvitge in
Barcelona, between May of 2016 and November 2018, diagnosed according to the DSM-5 [40] criteria,
and were between 18 and 60 years old.
Male participants referred for the Unit in that time period were excluded from the study, as the
number of them in our sample was too small for meaningful statistical comparisons (n = 21; four with
BN, eight with BED, two with OSFED, and seven with OBE). Considering the controversial results of
the presence of FA in AN [17], as well as the characteristic fears and cognitive distortions about food
and weight involved in AN that may influence patients understanding of what is considered excessive
food intake or abnormal eating behavior [41], patients diagnosed with AN were excluded from the
study as well. Likewise, due to the different reported prevalence of FA in OBE patients [20] compared
to OBE with a comorbid ED [14,15,17], the homogeneity of the sample was preserved by only inducing
patients with OBE without ED (n = 53), and only those with positive FA were included (n = 16).
According to the Declaration of Helsinki, the present study was approved by the Clinical Research
Ethics Committee (CEIC) of Bellvitge University Hospital (ethic approval code: PR205/17), and
written informed consent was obtained from all participants. All the assessments were conducted by
experienced psychologist and psychiatrists.
2.2. Assessment
For the assessment, anthropometric measures such as weight and height (without the participants
wearing clothes or shoes) were taken to calculate the BMI (i.e., weight (kg)/height (m2)). In addition to
clinically relevant variables (like age of onset or duration of the disorder) and sociodemographical
characteristics, a battery of the Spanish-validated versions of the following instruments was used.
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2.2.1. Eating Disorders Inventory 2 (EDI-2)
The Eating Disorders Inventory 2 (EDI-2) [42] is a 91-item multidimensional self-report
questionnaire answered on a 6-point Likert scale that assesses different cognitive and behavioral
characteristics typical for ED: Drive for Thinness, Bulimia, Body Dissatisfaction, Ineffectiveness,
Perfectionism, Interpersonal Distrust, Interoceptive Awareness, Maturity Fears, Asceticism, Impulse
Regulation, and Social Insecurity. The validated version for the Spanish population was developed by
Garner, 1998 [43], with a mean internal consistency of 0.63 (coefficient alpha).
2.2.2. Symptom Checklist-90-Revised (SCL-90-R)
The Symptom Checklist-90-Revised (SCL-90-R) [44] is used to evaluate a broad range of
psychological problems and symptoms of psychopathology. It consist of a 90-item questionnaire that
measures nine primary symptom dimensions: Somatization, Obsession-Compulsion, Interpersonal
Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism; and
includes three global indices: global severity index (overall psychological distress), positive symptom
distress index (the intensity of symptoms), and a positive symptom total (self-reported symptoms).
The global severity index can be used as a summary of the test. The validation of the scale in a Spanish
population [45], obtained a mean internal consistency of 0.75 (coefficient alpha).
2.2.3. Yale Food Addiction Scale 2.0 (YFAS-2)
The Yale Food Addiction Scale 2.0 (YFAS-2) [24] is a 35-item self-report questionnaire for measuring
FA during the previous 12 months. This original instrument (YFAS) was based on the Diagnostic
and Statistical Manual of Mental Disorders (DSM-IV-TR) criteria for substance dependence and was
adapted to the context of food consumption. The newer version of the instrument, YFAS-2, is based on
DSM-5 Criteria and evaluates 11 symptoms. The scale produces two measurements: (a) a continuous
symptom count score that reflects the number of fulfilled diagnostic criteria (ranging from 0 to 11),
and (b) a food addiction threshold based on the number of symptoms (at least 2) and self-reported
clinically significant impairment or distress. This final measurement allows for the binary classification
of food addiction (present versus absent). Additionally, based on the revised DSM-5 taxonomy, is
possible to establish severity cut-offs: mild (2–3 symptoms), moderate (4–5 symptoms), and severe
(6–11 symptoms). The translation and validation of the YFAS-2 for Spanish speaking samples with ED
was carried out by Granero et al. (2018) [13], showing excellent internal reliability coefficient (α = 0.94),
as well as an excellent accuracy in discriminating between healthy controls and ED subsamples
(κ = 0.75).
2.2.4. Temperament and Character Inventory-Revised (TCI-R)
The Temperament and Character Inventory-Revised (TCI-R) [46] is a 240-item, 5-point Likert scale,
questionnaire that measures four temperament dimensions (Harm Avoidance, Novelty Seeking, Reward
Dependence, and Persistence) and three character dimensions (Self-Directedness, Cooperativeness,
and Self-Transcendence) of personality. The Spanish validation in an adult population was carried out
by Gutiérrez-Zotes et al. [47]; the internal consistency (coefficient alpha) of the scales was 0.87.
2.3. Statistical Analysis
Statistical analysis was carried out with SPSS23 for Windows. Empirical clusters were explored
with the two-step-cluster procedure, using as indicators the ED severity level (EDI-2 scores), the global
psychopathological state (SCL-90-R scores), the personality profile (TCI-R scores), and the DSM-5
diagnostic subtype. Two-step-cluster used the log-likelihood distance measure through a multinomial
probability mass function for categorical variables and a normal density function for continuous
variables. This clustering technique has desirable features which makes it different from traditional
grouping and latent class techniques [48,49]: (a) scalability, which allows analysis of large data files by
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constructing a cluster-features-tree which is used as a summary of the records; (b) automatic selection
of the number of clusters-classes; and (c) handling of categorical and quantitative variables. Criteria
for the final model selected in this study were adequate goodness-of-fit (based on a cohesion and
separation index) and adequate clinical interpretability [50]. In this study, the Silhouettes coefficient
was used as a measure of the goodness of the final cluster solution. This coefficient estimates the
cohesion of the elements within a cluster and the separation between the clusters, and it ranges from –1
to +1 (being the values lower than 0.30 interpreted as poor fitting, between 0.30 and 0.50 as fair fitting,
and higher than 0.50 as good fitting [51]).
Comparison between clusters was based on chi-square tests (χ2) for categorical variables and
analysis of variance (ANOVA) for quantitative criteria. Effect size was measured through Cohen’s-d
coefficient for mean and proportion comparisons (low effect size was considered for |d| > 0.2, moderate
for |d| > 0.5, and large for |d| > 0.8; [52]). The Finner’s method was used to control Type-I error due to
multiple statistical comparisons (this procedure is included into the Familywise error rate stepwise
procedures and offers a more powerful test than the classical Bonferroni correction) [53].
3. Results
3.1. Characteristics of the Sample
All the participants in the analyses were women who met criteria for FA positive screening
score based on the YFAS-2 questionnaire n = 234. The distribution of the whole sample according to
diagnostic group was 16 OBE (without ED) (6.8%), 50 BED (21.4%), 119 BN (50.9%), and 49 OSFED
(20.9%). Most of the participants were single (62.0%, compared to 24.8% married or living with a
stable partner and 13.2% separated or divorced) and achieved primary (40.6%) or secondary (44.9%)
education levels. Table A1 (Appendix A) includes the distribution of the clinical profiles stratified and
compared by the diagnostic subtype.
3.2. Cluster Composition
The best grouping structure selected for the sample of the study was the three-cluster solution,
which coincided with the most optimal solution chosen by the two-step-cluster procedure. This solution
obtained a Silhouettes index (0.30) into the fair range, suggesting mild-moderate evidence of the cluster
structure in the data. The comparison between the largest cluster size (n = 90, 38.5%) and the smallest
(n = 60, 25.6%) yielded a ratio of 1.50.
Figure 1 summarizes the results of the clustering procedure: the bar-graph with the indicator
relevance for each variable (which reports how good each variable was for the grouping and can
differentiate between the derived clusters: the higher the importance of the measure, the less likely it
is that the variation for the variable between clusters is due to chance and the more likely it is due
to underlying differences) and the centroids (which summarizes the cluster patterns for the set of
variables and allows clinical interpretation of the empirical clusters). The indicator variables with the
highest contribution into the clustering were SCL-90-R scales measuring the symptom levels (concretely
psychotic, depressive, interpersonal sensitivity, anxiety, paranoia), followed by the EDI-2 scales
measuring ED severity (impulse regulation, social insecurity, and ineffectiveness). The personality
traits measured with the TCI-R obtained low relevance for the clustering, except for harm avoidance
(which achieved moderate-low capacity), as well as the diagnostic subtype (which achieved poor
capacity for the differentiation between the groups).
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Figure 1. Results of the clustering procedure. Note. EDI-2: Eating disorders Inventory 2. SCL-90-R:
Symptom Checklist-90-Revised. SCL-90-R Obsess-comp.: Obsession-Compulsion SCL-90-R subscale.
TCI-R: Temperament and Character Inventory-Revised.
3.3. Comparison between the Empirical Clusters
The first part of Table 1 contains the comparison between the three empirical clusters for the civil
status and the education levels. Differences between the groups only were found for the civil status:
compared with the other two groups, cluster 1 had the highest proportion of single participants.
The second block of Table 1 contains the comparison between the clusters for the clinical profile.
As a whole, clusters were ordered by the psychopathological state and personality profiles. Cluster 1
(n = 60, 25.6%) included the youngest participants (mean 28.8 years-old), with the lowest age of onset
(mean 18.5 years-old), the shortest duration of the eating problems (mean 10.5 years), and the lowest
BMI (mean 27.6 kg/m2), but with the highest severity in eating problems (the highest means in the
EDI-2), the worst psychopathological state (the highest means in the SCL-90R), the highest levels in the
personality traits of harm avoidance and self-transcendence, and the lowest levels in self-directedness
and cooperativeness. Cluster 1 was labeled in this study as the “dysfunctional cluster”.
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Table 1. Comparison between clusters for variables of the study.
Cluster 1 Cluster 2 Cluster 3 Pairwise Comparisons
n = 60 (25.6%) n = 90 (38.5%) n = 84 (35.9%) Cl1-Cl2 Cl1-Cl3 Cl2-Cl3
n % n % n % p |d| p |d| p |d|
Civil status—Single 46 76.7% 53 58.9% 46 54.8% 0.049 * 0.39 0.026 * 0.51 † 0.620 0.08
Married—Couple 10 16.7% 22 24.4% 26 31.0% 0.19 0.34 0.15
Separated—divorced 4 6.7% 15 16.7% 12 14.3% 0.32 0.25 0.07
Education Primary 29 48.3% 33 36.7% 33 39.3% 0.164 0.24 0.083 0.18 0.688 0.05
Secondary 27 45.0% 43 47.8% 35 41.7% 0.06 0.07 0.12
University 4 6.7% 14 15.6% 16 19.0% 0.29 0.38 0.09
Mean SD Mean SD Mean SD p |d| p |d| p |d|
Age (years-old) 28.77 11.05 35.66 12.99 34.54 12.13 0.001 * 0.57 † 0.006 * 0.50 † 0.546 0.09
Age of onset (years-old) 18.50 9.17 21.97 10.71 21.66 9.10 0.034 * 0.35 0.057 0.35 0.837 0.03
Duration (years) 10.49 9.10 14.30 10.20 12.64 8.72 0.016 * 0.39 0.177 0.24 0.246 0.17
YFAS-2: total criteria 8.22 2.66 9.59 1.80 7.55 2.77 0.001 * 0.61 † 0.102 0.25 0.001 * 0.87 †
BMI (kg/m2) 27.55 11.13 30.29 9.08 31.48 10.99 0.114 0.27 0.025 * 0.36 0.447 0.12
EDI-2: Drive for thinness 17.67 2.84 15.60 4.82 13.77 4.83 0.005 * 0.52 † 0.001 * 0.98 † 0.007 * 0.38
EDI-2: Body dissatisfaction 21.60 5.61 20.44 6.52 17.18 7.06 0.288 0.19 0.001 * 0.69 † 0.001 * 0.51 †
EDI-2: Interoceptive awar. 18.25 5.77 15.54 5.33 8.19 5.12 0.003 * 0.52 † 0.001 * 1.84 † 0.001 * 1.41 †
EDI-2: Bulimia 8.68 5.30 11.67 3.85 6.92 4.69 0.001 * 0.64 † 0.023 0.35 0.001 * 1.11 †
EDI-2: Interpers.distrust 9.35 5.23 7.08 4.76 4.12 3.89 0.003 * 0.52 † 0.001 * 1.14 † 0.001 * 0.68 †
EDI-2: Ineffectiveness 18.73 6.57 15.27 6.06 7.08 4.50 0.001 * 0.55 † 0.001 * 2.07 † 0.001 * 1.53 †
EDI-2: Maturity fears 12.70 5.69 9.03 5.37 6.19 5.18 0.001 * 0.66 † 0.001 * 1.20 † 0.001 * 0.54 †
EDI-2: Perfectionism 7.67 4.63 6.53 4.21 4.52 3.65 0.101 0.26 0.001 * 0.75 † 0.002 * 0.51 †
EDI-2: Impulse regulation 13.63 5.46 7.50 4.38 3.27 3.41 0.001 * 1.24 † 0.001 * 2.27 † 0.001 * 1.08 †
EDI-2: Ascetism 10.45 3.18 8.88 2.78 5.69 2.91 0.001 * 0.53 † 0.001 * 1.56 † 0.001 * 1.12 †
EDI-2: Social Insecurity 13.40 4.54 9.60 4.10 4.51 3.03 0.001 * 0.88 † 0.001 * 2.30 † 0.001 * 1.41 †
EDI-2: Total 152.13 27.03 127.14 20.64 81.45 22.16 0.001 * 1.04 † 0.001 * 2.86 † 0.001 * 2.13 †
SCL-90-R: somatization 2.75 0.63 2.13 0.71 1.46 0.72 0.001 * 0.93 † 0.001 * 1.92 † 0.001 * 0.94 †
SCL-90-R: obsess-comp. 2.83 0.59 2.34 0.57 1.53 0.64 0.001 * 0.84 † 0.001 * 2.11 † 0.001 * 1.34 †
SCL-90-R: interpers.sens. 3.03 0.53 2.50 0.54 1.38 0.67 0.001 * 1.00 † 0.001 * 2.73 † 0.001 * 1.84 †
SCL-90-R: depressive 3.24 0.43 2.68 0.53 1.67 0.62 0.001 * 1.17 † 0.001 * 2.93 † 0.001 * 1.74 †
SCL-90-R: anxiety 2.76 0.55 1.96 0.64 1.08 0.54 0.001 * 1.36 † 0.001 * 3.09 † 0.001 * 1.49 †
SCL-90-R: hostility 2.32 0.88 1.43 0.73 0.87 0.67 0.001 * 1.10 † 0.001 * 1.86 † 0.001 * 0.81 †
SCL-90-R: phobic anxiety 2.04 0.83 1.32 0.79 0.51 0.52 0.001 * 0.89 † 0.001 * 2.22 † 0.001 * 1.21 †
SCL-90-R: paranoia 2.48 0.62 1.57 0.59 0.87 0.53 0.001 * 1.50 † 0.001 * 2.77 † 0.001 * 1.25 †
SCL-90-R: psychotic 2.31 0.52 1.56 0.45 0.85 0.48 0.001 * 1.55 † 0.001 * 2.92 † 0.001 * 1.53 †
SCL-90-R: GSI index 2.73 0.36 2.06 0.33 1.26 0.38 0.001 * 1.90 † 0.001 * 3.96 † 0.001 * 2.26 †
SCL-90-R: PST index 81.63 6.60 71.93 8.36 55.42 13.26 0.001 * 1.29 † 0.001 * 2.50 † 0.001 * 1.49 †
SCL-90-R: PSDI index 3.01 0.34 2.60 0.36 2.03 0.36 0.001 * 1.20 † 0.001 * 2.81 † 0.001 * 1.57 †
TCI-R: Novelty seeking 103.32 16.27 99.00 16.77 100.79 14.63 0.105 0.26 0.347 0.16 0.460 0.11
TCI-R: Harm avoidance 133.15 13.32 126.94 16.59 109.63 16.15 0.018 * 0.41 0.001 * 1.59 † 0.001 * 1.06 †
TCI-R: Reward-depend. 95.83 17.43 98.68 15.33 103.25 15.83 0.289 0.17 0.007 * 0.45 0.062 0.29
TCI-R: Persistence 103.42 22.25 102.77 20.58 107.33 19.98 0.852 0.03 0.267 0.19 0.149 0.23
TCI-R: Self-directedness 96.03 13.89 104.39 15.30 124.70 17.28 0.002 * 0.57 † 0.001 * 1.83 † 0.001 * 1.24 †
TCI-R: Cooperativeness 124.40 19.00 133.38 16.53 139.31 11.39 0.001 * 0.50 † 0.001 * 0.95 † 0.013 * 0.42
TCI-R: Self-transcendence 73.35 13.87 63.43 15.43 63.73 17.46 0.001 * 0.68 † 0.001 * 0.61 † 0.903 0.02
Note. SD: standard deviation. * Bold: significant comparison (0.05 level). † Bold: effect size into the
moderate (|d| > 0.50) to high range (|d| > 0.80). YFAS-2: Yale food addiction scale 2.0. BMI: Body mass index.
EDI-2: Eating disorders Inventory 2. SCL-90-R: Symptom Checklist-90-Revised. TCI-R: Temperament and
Character Inventory-Revised.
Cluster 2 (n = 90, 38.5%) included the participants with the longest duration of the eating problems
(mean 14.3 years) and the highest level of food addiction (mean 9.6). The mean for BMI (30.3 kg/m2)
was higher than in cluster 1, but similar to that obtained in cluster 3. The mean scores in the EDI-2
and the SCL-90R were high for participants into cluster 2, but clearly lower than values registered for
cluster 1. Cluster 2 was labeled in this study as the “moderate cluster”.
Cluster 3 (n = 84, 35.9%) was characterized by similar mean scores in age (34.5 years-old), onset
of eating problems (21.7 years) and duration of the disorder (12.6 years) than cluster 2. The most
adaptive scores in the clinical profile was registered for cluster 3 (the lowest scores in the EDI-2 and the
SCL-90R), as well as the highest means in the personality traits of persistence, self-directedness and
cooperativeness. Cluster 3 was labeled in this study as the “functional cluster”.
Figure 2 includes the 100%-stacked bar chart with the distribution of the DSM-5 ED diagnostic
subtype into each empirical cluster. OBE patients were primary included into cluster 3 (68.85),
while BED patients were mostly distributed into clusters 3 and 2 (48.0% and 44.0%, respectively).
Approximately half of the BN patients were into cluster 2 (52.1%), and the remaining participants into
this group were distributed between cluster 1 (27.7%) and cluster 3 (20.2%). A little more than half of
the OSFED patients were in cluster 3 (51%), and almost 41% in cluster 1.
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4. Discussion
The aim of the present study was to explor irical severity clusters with FA-positive (FA+)
females, and to investigate whether these FA clusters differed by ED and OBE. A three-cluster structure
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was detected based on general psychopathology, ED severity, and personality traits. These clusters
ranged from a more functional cluster, to moderate and highly dysfunctional group.
Although high FA has previously been associated with high eating psychopathology and more
dysfunctional personality traits, [32], this is the first study that analyzes a potential heterogeneity
within patients with FA. Although all the participants in the current study were FA+, we found that the
identified clusters followed a linearity with respect to FA severity with the most dysfunctional clusters
(1 and 2) having the highest FA symptoms level, and the most functional one, the lowest. For the
“dysfunctional cluster”, we found a higher prevalence of OSFED and BN, both ED conditions
characterized by more dysfunctional personality traits, greater impulsivity, and more general
psychopathology, [54–57], as well by their worse prognosis [56]. Consistent with this literature,
the cluster with more OFED and BN had the worst psychopathological state and highest severity in
ED symptomatology.
Personality traits that were elevated in the most dysfunction cluster were greater difficulties in
establishing goals and objectives to guide their lives (self-directedness), the highest levels of anxiety,
worry, fear (harm avoidance), and being a more self-centered person (lower cooperativeness). All of
these characteristics have not only been associated with FA [32,35], but also with BN, substance use
disorders (SUD), and comorbidity between BN and SUD [58,59]. This cluster was also associated with
higher levels of novelty seeking, which is a predictor of risky behaviors and associated with SUD and
ED pathologies [59–64]. Therefore, the commonality of these extreme personality features in addictive
profiles, suggests it could be important in the etiology and maintenance of FA and could be the focus of
intervention efforts. Additionally, the aforementioned characteristics have been related to higher risk of
dropout and poor outcome in OSFED patients with purging behaviors [56], suggesting important clinical
relevance. Although the association of FA and treatment outcome was not the aim of this study, prior
research suggests that higher initial FA scores have been associated with a worse prognosis in BN [65].
In sum, the severity of this dysfunctional cluster may be driven by the comorbid ED provided and
characteristics associated with these disorders. Thus, in order to be successful, the treatment aimed at
patients who are in this cluster should target its principal psychological and psychiatric characteristics,
in addition to factors that may maintain FA. As previous literature has reported, changes in personality
traits are related to an overall improvement in eating pathology [66], and interventions that could
target the personality factors elevated in this cluster would likely be of benefit. Additionally, due to
the severity of the psychopathological state in this cluster, pharmacological approaches to address
comorbid psychiatric conditions could be also considered if it is needed.
The second cluster, the moderate cluster, was the one that presented the highest level of FA, although
functioning was more adaptive than cluster 1 (i.e., lower ED severity, intermediate psychopathology
levels). Therefore, we hypothesize that it is FA which mostly determines the characteristics of this
cluster. Regarding the personality traits, high levels of harm avoidance and low self-directedness were
present in this cluster, but at moderate levels compared to cluster 1 (the dysfunctional). Related to the
ED pathology, there was a high presence of patients with BN followed by patients with BED within this
cluster. Higher FA scores have been already associated with bingeing ED-subtype patients [13,14,17,67],
given the tendency to consume more high-fat/high-sugar caloric food during binges episodes, which
may result in a higher number of FA symptoms [17] given the similar neural responses in reward
pathways modulated by dopamine by those types of food and addictive drugs [6,16,29,68–70]. In fact,
new maintenance models of BN and BED have emerged, that take into consideration the addictive
response to palatable foods [71]. Related studies have also found that similar patterns of neural
underpinning of tolerance and dependence observed in SUD appear to be related to binge-type eating
disorders as well [72,73]. This is consistent with the high comorbidity between SUD and binge-type
ED [74,75]. Finally, another important aspect to mention is that it has been shown that individuals
with BN or BED experience more frequent and more intense food cravings than persons without binge
eating [76–79] and that both conditions show significantly larger food cue reactivity (self-reported
craving) [80]. This intense desire or urge to eat a particular type of food also, at a neural level, resembles
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responses to drug cues in SUD [26]. Therefore, it could be suggested that the treatment directed
to patients in this cluster should target the reward related neural processes that maintain addictive
disorders. In this regard, it has been suggested that previously developed interventions for addictions
could be applied to binge eating behaviors [71], such as training in the reduction of food cue reactivity
in order to reduce craving [81,82] and a reduction in the intake of high-fat/high-sugar caloric food
which hyper-activate reward systems.
The “adaptative” cluster presents with more functional personality traits and low levels of general
psychopathology, as well as the lowest levels of FA. Thus, the FA in this cluster may be the result of
different factors than patients in clusters 1 and 2, which could have important implications in the
treatment. First, it is important to mention that within this cluster, there was the highest presence of
patients with OBE without ED. This is consistent with prior findings that patients with OBE with a
comorbid ED have a higher level of psychopathology than OBE patients without ED [83–86]. Second,
this cluster presents the most functional personality traits, the lowest levels of harm avoidance and
self-transcendence, and the highest in cooperativeness and self-directedness. Similar results have
been found in healthy control groups when comparing them with ED and behavioral addiction
patients [87,88]. Thus, BMI could be playing an important role in this cluster, considering that in our
sample there are statistically significant differences between cluster 1 (the dysfunctional) and 3 (the
adaptative) in BMI. It has been suggested that visceral adiposity levels could be a mediator of the
relationship between middle-dorsal insula network connectivity (insula region relevant for eating
behavior) and food craving [28], being that visceral fat disrupts insula coding of bodily homeostatic
signals, which may boost externally driven food cravings, and also, there are positive associations
between food craving and excessive overeating [89,90]. Given the characteristics of this cluster, for
which no dysfunctional personality traits of severe ED symptomology or psychopathology must
be addressed, it could be hypothesized that nutritional changes that would have a positive impact
on a reduction of BMI could be also be beneficial for the reducing FA, through reducing craving
episodes. This is consistent with previous studies that find that FA decreases significantly after bariatric
surgery [91], and that the induced weight loss by the surgery resulted in the remission of FA in 93% of
patients [22]. Finally, there is a moderate representation of patients with BED in this cluster, which
may be due to the common co-occurrence between both conditions (OBE-BED). This may be due
to the association of features such as grazing [92], craving [93–95], or hedonic [96] and emotional
eating [97,98] with OBE and BED. Addressing these factors (and their negative consequences) could be
an important focus of treatment in this FA cluster, as grazing is associated with poorer weight loss
treatment outcomes in OBE [92] and craving and the use of food to regulate mood are potential triggers
for overeating [41,99,100].
The results of this study should take into account the following limitations. First, the sample only
included women, so the results cannot be generalized to males; for future studies, it will be important
to explore if the FA cluster structure found in this study is replicated in males. Another limitation is
that the size of some of the participant groups, divided by ED subtype and OBE, is small. Finally that,
due to the fact that the participants were recruited in the same geographical area, the results may not
be generalizable to other samples
5. Conclusions
The findings in the present study describe a three-cluster structure of FA-positive (FA+) participants
that differ by ED and OBE profile. The clusters range from more to less functional, depending on
psychopathology and personality traits. The identification of phenotypes in FA will not only increase
knowledge of each cluster’s characteristics, but may allow for better individualization of treatment by
identifying novel intervention targets and improving treatment outcomes. Likewise, the present study
identifies future lines of research, as longitudinal studies that could analyze the predictive validity of
this cluster structure on treatment outcome could be of importance.
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Appendix A
Table A1. Clinical profiles in the ED-subtypes.
Obesity BED BN OSFED
n = 16 n = 119 n = 50 n = 49
α Mean SD Mean SD Mean SD Mean SD p
Age (years-old) 44.13 11.89 40.90 12.62 31.31 11.23 27.73 9.94 <0.001 *
Age of onset (years-old) 26.06 11.44 25.90 11.18 19.32 9.14 18.29 6.91 <0.001 *
Duration (years) 18.75 9.94 14.79 9.79 12.26 9.24 9.81 8.53 0.003
YFAS2.0: total criteria 0.943 8.19 2.51 9.54 1.68 9.00 2.18 6.35 2.97 <0.001 *
BMI (kg/m2) 44.64 8.33 40.46 10.06 26.72 6.85 22.59 4.13 <0.001 *
EDI-2: Drive for thinness 0.736 12.31 3.32 12.82 5.19 16.44 4.23 16.88 3.81 <0.001 *
EDI-2: Body dissatisfaction 0.842 20.19 6.47 21.74 5.63 19.40 6.86 17.55 7.06 0.019
EDI-2: Interoceptive
awareness 0.785 11.56 7.12 12.30 6.96 14.69 6.66 12.94 6.58 0.078
EDI-2: Bulimia 0.710 6.13 4.67 10.08 3.72 10.91 4.53 5.14 4.63 <0.001 *
EDI-2: Interpersonal distrust 0.802 5.38 4.53 6.52 5.30 7.28 5.09 5.43 4.55 0.121
EDI-2: Ineffectiveness 0.860 12.25 7.84 11.72 6.45 14.78 7.52 11.27 7.41 0.011 *
EDI-2: Maturity fears 0.784 8.06 6.92 7.06 5.95 9.79 5.65 9.14 5.95 0.048 *
EDI-2: Perfectionism 0.697 5.75 4.16 5.84 3.91 6.69 4.45 5.06 4.26 0.146
EDI-2: Impulse regulation 0.757 4.50 4.47 5.74 5.36 8.56 6.15 7.96 5.73 0.005 *
EDI-2: Ascetic 0.717 8.00 3.76 7.24 3.35 8.70 3.58 7.73 3.21 0.071
EDI-2: Social Insecurity 0.770 6.19 5.39 7.76 4.76 9.90 5.38 7.80 4.62 0.004 *
EDI-2: Total 0.928 100.31 34.62 108.82 33.40 127.13 34.96 106.90 38.03 <0.001 *
SCL-90-R: somatization 0.875 2.07 0.93 2.02 0.75 2.13 0.83 1.88 0.98 0.408
SCL-90-R: obsess-comp. 0.818 1.88 0.94 2.06 0.80 2.29 0.72 2.10 0.85 0.094
SCL-90-R: interpers.sens. 0.854 1.91 1.13 2.02 0.93 2.40 0.83 2.14 0.87 0.024 *
SCL-90-R: depressive 0.878 2.12 1.06 2.30 0.88 2.60 0.76 2.40 0.84 0.044 *
SCL-90-R: anxiety 0.865 1.36 0.86 1.62 0.87 1.98 0.84 1.92 0.90 0.008 *
SCL-90-R: hostility 0.840 0.99 0.71 1.26 0.81 1.59 0.98 1.49 0.94 0.035 *
SCL-90-R: phobic anxiety 0.800 1.13 0.93 0.97 0.86 1.31 0.94 1.25 0.96 0.179
SCL-90-R: paranoia 0.745 1.63 0.97 1.42 0.85 1.64 0.83 1.46 0.85 0.355
SCL-90-R: psychotic 0.788 1.21 0.67 1.25 0.73 1.61 0.70 1.59 0.80 0.009 *
SCL-90-R: GSI index 0.971 1.69 0.80 1.77 0.67 2.06 0.64 1.91 0.71 0.025 *
SCL-90-R: PST index 0.971 60.81 20.65 65.24 15.58 71.10 12.26 67.98 15.03 0.012 *
SCL-90-R: PSDI index 0.971 2.44 0.59 2.38 0.55 2.57 0.50 2.48 0.53 0.162
TCI-R: Novelty seeking 0.782 94.69 14.06 100.80 15.70 101.85 17.34 100.00 12.76 0.394
TCI-R: Harm avoidance 0.873 117.69 19.22 120.28 17.00 124.04 18.74 121.73 18.85 0.440
TCI-R: Reward-depend. 0.834 108.94 17.06 99.20 16.70 97.74 15.58 101.43 16.48 0.057
TCI-R: Persistence 0.893 103.94 15.64 97.26 20.19 104.36 21.44 112.76 18.92 0.003 *
TCI-R: Self-directedness 0.844 115.31 23.31 108.64 20.65 106.87 18.25 115.06 19.58 0.054
TCI-R: Cooperativeness 0.844 139.88 11.85 131.56 20.63 132.02 16.52 135.59 12.66 0.195
TCI-R: Self-transcendence 0.863 72.38 21.29 66.14 16.53 65.84 14.92 64.55 17.63 0.420
Note. α: Cronbach’s alpha in the sample. BED: binge eating disorder; BN: bulimia nervosa; OSFED: other specified
feeding eating disorder. SD: standard deviation. * Bold: significant comparison (.05 level). YFAS: Yale food addiction
scale 2.0. BMI: Body mass index. EDI-2: Eating disorders Inventory 2. SCL-90-R: Symptom Checklist-90-Revised.
TCI-R: Temperament and Character Inventory-Revised.
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